Replimune Group, Inc.

REPL

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001737953

SEC filings (opens in a new tab)

In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Replimune Group, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of REPL: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	157	1	167	+11
Shares	77.9M	667.6K	82.0M	+4.76M (+6.2%)
Value	$943.2M	$8.09M	$799.3M	−$135.8M (−14.5%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Replimune Group, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to REPL in Q1 2025
Institution	Shares	Value	% of portfolio
Nuveen, LLC	671,411	$6.55M	0.00%
Catalio Capital Management, LP	355,640	$3.47M	0.86%
Balyasny Asset Management LLC	333,237	$3.25M	0.01%
Ensign Peak Advisors, Inc	322,402	$3.14M	0.01%
Moody Aldrich Partners LLC	197,385	$1.92M	0.40%
SummitTX Capital, L.P.	109,071	$1.06M	0.05%
Panagora Asset Management Inc	106,484	$1.04M	0.01%
Qube Research & Technologies Ltd	52,780	$514.6K	0.00%
Cantor Fitzgerald, L. P.	40,000	$390.0K	0.01%
NEOS Investment Management LLC	37,522	$365.8K	0.01%
Tema ETFs LLC	37,522	$365.8K	0.11%
Dynamic Technology Lab Private Ltd	35,139	$343.0K	0.05%
Glenmede Trust Co NA	25,917	$252.7K	0.00%
Envestnet Asset Management Inc	15,405	$150.2K	0.00%
CIBC World Markets Corp	15,211	$148.3K	0.00%
Optimize Financial Inc	14,379	$140.2K	0.05%
Virtus Investment Advisers, Inc.	13,434	$131.0K	0.04%
Axq Capital, LP	12,191	$118.9K	0.05%
Simplex Trading, LLC	5,646	$55.0K	0.00%
Coldstream Capital Management Inc	397	$3.87K	0.00%
Boston Private Wealth LLC	391	$3.81K	0.00%
UMA Financial Services, Inc.	73	$712	0.00%
TD Private Client Wealth LLC	48	$468	0.00%
Parkside Financial Bank & Trust	45	$439	0.00%
Stephens Consulting, LLC	35	$342	0.00%
Creative Financial Designs Inc	33	$322	0.00%

Sold out (15)

Institutions that held Replimune Group, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of REPL in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Soleus Capital Management, L.P.	262,500	$3.18M
Crestline Management, LP	172,202	$2.09M
Connor, Clark & Lunn Investment Management Ltd.	107,416	$1.30M
Jump Financial, LLC	71,443	$865.2K
HRT Financial LP	65,625	$794.0K
Los Angeles Capital Management LLC	34,547	$418.4K
Verition Fund Management LLC	23,328	$282.5K
Meeder Asset Management Inc	16,909	$204.8K
Freestone Grove Partners LP	11,589	$140.3K
XTX Topco Ltd	11,337	$137.3K
Quantinno Capital Management LP	10,455	$126.6K
Point72 Asia (Singapore) Pte. Ltd.	9,650	$116.9K
Virtus ETF Advisers LLC	5,818	$70.5K
Venturi Wealth Management, LLC	401	$4.86K
R Squared Ltd	180	$2.18K

Not filed for Q1 2025 yet (1)

Institutions that held Replimune Group, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding REPL in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	667,634	$8.09M